TITLE

Radiological intervention for haemoptysis in cystic fibrosis

AUTHOR(S)
Ashleigh, R. J.; Webb, A. K.
PUB. DATE
June 2007
SOURCE
Journal of the Royal Society of Medicine (Supplement);Jun2007, Vol. 100 Issue 47, p38
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the use of trans-arterial embolization in the treatment of a common cystic fibrosis (CF) complication called haemoptysis. Classifications of haemoptysis is also presented which include massive haemoptysis which can lead to asphyxiation and non-massive haemoptysis where bleeding is debilitating. Initial control of hemoptysis through bronchial embolization is achieved of over 90% of patients.
ACCESSION #
36604428

 

Related Articles

  • Estrapleural Bronchial Artery Ligation for Life-Threatening Hemoptysis in Cystic Fibrosis. Kaukuntla, MD, H. K.; Amer, K. M. A.; Honeybourne, D.; Stableforth, D. E.; Khalil-Marzouk, J. F. // Angiology;Sep2000, Vol. 51 Issue 9, p787 

    Assesses the role of extrapleural approach for bronchial artery ligation in the treatment of recurrent hemoptysis in cystic fibrosis patients. Effect of the need for lung transplantation on the desirability of artery ligation; Presentation of indications, surgical experience and outcome;...

  • Stress, Rage, And Hemoptysis. Petty, Thomas L. // Cortlandt Forum;05/25/2001, Vol. 14 Issue 5, p62 

    Reports on the treatment of a Jordan-based attorney with recurrent episodes of coughing up large amounts of red blood. Results of chest radiography and other examinations; Conclusion that stress and hypertension are factors for the coughing; Findings from a bronchial arteriogram; Hemoptysis...

  • Stopping bleeding by embolisation. Reidy, J.F. // British Medical Journal (Clinical Research Edition);3/7/1987, Vol. 294 Issue 6572, p592 

    Focuses on the use of transcatheter embolization as bleeding medication. Complications of bleeding; Assessment of efficacy of embolous materials and techniques; Application of infusion of intra-arterial vapopressin.

  • Transcatheter arterial embolization for gastroduodenal ulcer bleeding: the use of cyanoacrylate glue has gained acceptance. Loffroy, Romaric // Acta Radiologica;Apr2014, Vol. 55 Issue 3, p325 

    A letter to the editor is presented in response to the article related to the outcomes of transcatheter arterial embolization (TAE) using N-butyl cyanoacrylate (NBCA) in patients with acute arterial bleeding from gastroduodenal ulcers in the previous issue.

  • Response to “Transcatheter arterial embolization for gastroduodenal ulcer bleeding: the use of cyanoacrylate glue has gained acceptance”. Mine, Takahiko; Murata, Satoru; Kumita, Shin-ichiro // Acta Radiologica;Apr2014, Vol. 55 Issue 3, p327 

    A response from the author of the article related to the outcomes of transcatheter arterial embolization (TAE) using N-butyl cyanoacrylate (NBCA) in patients with acute arterial bleeding from gastroduodenal ulcers in the previous issue is presented.

  • Lucina - May 2012.  // Archives of Disease in Childhood;May2012, Vol. 97 Issue 5, p484 

    The article offers information related to researches on child health and diseases. A trial in Germany has confirmed that administration of surfactant through a thin intratracheal catheter to preterm infants receiving nasal continuous positive airway pressure (CPAP) could eliminate mechanical...

  • New drug for cystic fibrosis shows promise.  // Modern Medicine;Feb95, Vol. 63 Issue 2, p56 

    Presents an abstract of the article `Effect of Aerosolized Recombitant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis by H.J. Fuchs, D.S. Borowitz, et al from the periodical `The New England Journal of Medicine,' dated September 8,...

  • Cystic fibrosis therapy, detection improving.  // Newsweek;5/12/1986, Vol. 107 Issue 19, p69 

    Cystic fibrosis is one of the cruelest and most common genetically transmitted illnesses in the US, with more than 30,000 sufferers at any given time. Now, however, improvements in treatments are extending the lives of cystic fibrosis patients, and recent developments in biotechnology are...

  • Liberated lungs.  // New Scientist;8/21/93, Vol. 139 Issue 1887, p11 

    Reports on the recommendation for the approval of the pulmozyme drug by the Pulmonary-Allergy Drugs Advisory Committee to the Food and Drug Administration. Treatment for cystic fibrosis; Improvement of lung function; Alleviation of lung symptoms; Side effects.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics